Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel chiral synthesis of Rasagiline Mesylate from 1-indanone. High yield, low cost, industrial scale-up ready for Parkinson's API intermediates.
Novel patent CN103980139A details efficient synthesis route offering supply chain stability and cost reduction for pharmaceutical intermediate manufacturing.
Patent CN121108055A reveals a novel acyl chloride treatment for Bifonazole, ensuring >99% purity and simplified manufacturing for reliable global supply chains.
Advanced purification technology for Halometasone Carboxylate ensuring single impurity ≤0.1%. Reliable pharmaceutical intermediates supplier offering cost-effective scale-up solutions.
Patent CN115028661A details a novel synthesis for 4-aminopiperidine-1-methyl phosphate, offering cost reduction in API manufacturing and scalable routes for antitumor drug precursors.
Patent CN104649934B reveals high-yield trifluoromethylation. Offers supply chain stability and cost reduction for pharmaceutical intermediate manufacturing.
Patent CN103044467A details a scalable route for R-(1-amino-3-methyl)butyl pinacol borate, eliminating cryogenic conditions and column chromatography for cost-effective manufacturing.
Novel patent CN113717063B details safer tulobuterol production. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Novel synthesis route for Mosapride Citrate intermediate ensures high yield and purity. Cost-effective scalable solution for global pharmaceutical supply chains.
Patent CN1195761C reveals a novel route for high-purity cephalosporin intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN105624215B reveals a 7-step synthesis of calcipotriol from stigmasterol. This route offers significant cost reduction and scalability for vitamin D analog manufacturing.
Novel antineoplastic biphenylurea synthesis via Suzuki coupling. Offers mild conditions and scalable routes for cost reduction in API manufacturing.
Novel palladium-catalyzed synthesis of 2,5-diaminopyrroles. Mild conditions, high yield, scalable for pharmaceutical intermediates and fine chemicals.
Patent CN109912426B reveals a cost-effective route for (2R,5R)-1,6-diphenyl-2,5-hexanediamine. Discover scalable manufacturing solutions for HIV drug intermediates.
Patent CN109942418A reveals a novel cyclopentadiene-based catalyst enhancing stereoselectivity. Discover cost reduction in chiral compound manufacturing and reliable supply chain solutions.
Advanced synthesis of Irbesartan key intermediates via mild amidine cyclization. High-purity pharma intermediates with optimized cost and scalable manufacturing processes.
Patent CN113527382B reveals a novel MPLA synthesis route using Nap protection. Achieve higher purity and cost reduction in vaccine adjuvant manufacturing with scalable methods.
Novel titanium-mediated route eliminates palladium catalysts, offering significant cost reduction and scalable production for high-purity pharmaceutical intermediates.
Patent CN113527050B reveals a novel Nap-protected MPLA intermediate synthesis. This method eliminates hydrogenation, ensuring high purity and scalable supply for vaccine adjuvant manufacturing.
Novel synthesis route for thiohydantoin drugs avoiding toxic reagents. Improved yield and safety for commercial scale-up of androgen receptor antagonists.